Methods: The diabetes registries have been used for data storage, patient reminders, proactive care monitoring, and physician alerts, among other things, the goals primarily being improvements in quality of care and reduction in hospitalization rates. The main question is: could the high dollar investments in electronic registries be justified, and could diabetes registries lower the cost of treatment?

Results: Our critical data analysis of some countries North America, Europe, and Asia reveals that the quality of care has improved with the introduction of diabetes registries in these countries. At the moment, the effects of diabetes registries on healthcare policies are not clear, and more studies are needed to affirm claims about the cost-saving potential of diabetes registries. The main findings of our analysis are that medical teams would have to shift their focus from population care to individual care, use the plethora of information in the database to identify vulnerable individuals, and to preempt the emergence of complications of both type of diabetes.

Conclusions: The present data analyses of several countries strongly recommend that those in charge of diabetes registries should regularly engage with the various stakeholders-insurance companies, pharmaceutical companies, employers, and governments-involved, and should design healthcare policies that deliver low-cost, high value care and address the racial and ethnic biases surrounding healthcare.